1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "252003-65-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-13302

    VEGFR FGFR Cancer
    CP-547632 is a well-tolerated, orally-bioavailable inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases with IC50s of 11 nM and 9 nM, respectively. CP-547632 is an ATP-competitive kinase inhibitor and it is selective relative to epidermal growth factor receptor, platelet-derived growth factor β, and other related TKs. CP-547632 has antitumor efficacy.